Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 5
2005 5
2006 5
2007 4
2008 6
2009 7
2010 8
2011 16
2012 4
2013 4
2014 6
2015 4
2016 8
2017 10
2018 12
2019 10
2020 10
2021 11
2022 5
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma.
Patiño-García A, Guruceaga E, Andueza MP, Ocón M, Fodop Sokoudjou JJ, de Villalonga Zornoza N, Alkorta-Aranburu G, Uria IT, Gurpide A, Camps C, Jantus-Lewintre E, Navamuel-Andueza M, Sanmamed MF, Melero I, Elgendy M, Fusco JP, Zulueta JJ, de-Torres JP, Bastarrika G, Seijo L, Pio R, Montuenga LM, Hernáez M, Ochoa I, Perez-Gracia JL. Patiño-García A, et al. Among authors: camps c. EBioMedicine. 2024 Apr;102:105048. doi: 10.1016/j.ebiom.2024.105048. Epub 2024 Mar 13. EBioMedicine. 2024. PMID: 38484556 Free PMC article.
Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry.
Provencio M, Cobo M, Rodriguez-Abreu D, Carcereny E, Cantero A, Calvo V, López Castro R, Bernabé R, Bosch-Barrera J, Massutí B, García Campelo R, Sánchez-Hernández A, Laura Ortega A, Guirado M, Del Barco E, Camps C, Casal-Rubio J, Dómine M, Angeles Sala M, Padilla A, Luís González Larriba J, de Asís Aparisi F; Spanish Lung Cancer Group SLCG/GECP. Provencio M, et al. Among authors: camps c. Lung Cancer. 2024 Apr;190:107513. doi: 10.1016/j.lungcan.2024.107513. Epub 2024 Feb 29. Lung Cancer. 2024. PMID: 38432027
Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients.
Candal-Pedreira C, Ruano-Ravina A, Calvo de Juan V, Cobo M, Trigo JM, Rodríguez-Abreu D, Estival A, Carcereny E, Cucurull M, López Castro R, Medina A, García Campelo R, Cordeiro González P, Sánchez-Gastaldo A, Bosch-Barrera J, Massutí B, Dómine M, Camps C, Ortega AL, Sánchez-Hernández A, Guirado Risueño M, Del Barco Morillo E, Garrido Fernández A, Provencio M. Candal-Pedreira C, et al. Among authors: camps c. Arch Bronconeumol. 2024 Feb;60(2):88-94. doi: 10.1016/j.arbres.2023.12.005. Epub 2023 Dec 18. Arch Bronconeumol. 2024. PMID: 38160163 Free article. English, Spanish.
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.
Postel-Vinay S, Coves J, Texier M, Aldea M, Gazzah A, Dómine M, Planchard D, De Las Peñas R, Sala Gonzalez MA, Viteri S, Perez J, Ortega AL, Moran T, Camps C, Lopez-Martin A, Provencio M, Soria JC, Besse B, Massuti B, Rosell R. Postel-Vinay S, et al. Among authors: camps c. Br J Cancer. 2024 Feb;130(3):417-424. doi: 10.1038/s41416-023-02514-5. Epub 2023 Dec 14. Br J Cancer. 2024. PMID: 38097741 Clinical Trial.
Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study.
Candal-Pedreira C, Ruano-Ravina A, Calvo de Juan V, Cobo M, Trigo JM, Carcereny E, Cucurull M, López Castro R, Solís García E, Sánchez-Gastaldo A, Massutí B, Rodríguez-Abreu D, Estival A, Guirado Risueño M, Pamiés Ramón M, García Campelo R, Alonso-Jáudenes G, Camps C, Del Barco Morillo E, González Ojea C, Dómine M, Sanchez-Hernandez A, Bosch-Barrera J, Sala González MÁ, Provencio M. Candal-Pedreira C, et al. Among authors: camps c. ERJ Open Res. 2023 Dec 4;9(6):00468-2023. doi: 10.1183/23120541.00468-2023. eCollection 2023 Nov. ERJ Open Res. 2023. PMID: 38076676 Free PMC article.
Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study.
Provencio M, Carcereny E, López Castro R, Calvo V, Rodríguez Abreu D, Cobo M, Ortega AL, Bernabé R, Guirado M, Massutí B, Del Barco-Morillo E, Bosch-Barrera J, Camps C, Carroll R, Rault C, Chaib C, Penrod J, Vo L, Ralphs E, Daumont MJ. Provencio M, et al. Among authors: camps c. Transl Lung Cancer Res. 2023 Oct 31;12(10):2113-2128. doi: 10.21037/tlcr-23-176. Epub 2023 Oct 27. Transl Lung Cancer Res. 2023. PMID: 38025806 Free PMC article.
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
Aparicio I, Iranzo P, Reyes R, Bote H, Saigi M, Bringas M, Bosch-Barrera J, Corral J, Aparisi F, Ruffinelli JC, Jiménez B, Lage Y, López-Castro R, Majem M, Vázquez S, Artal Á, Rodríguez-Pérez Á, Lázaro-Quintela M, Torres JMS, Reguart N, Cucurull M, Gil-Bazo I, Camps C, Nadal E, Del Barrio A, Garrido P, Dómine M, Álvarez R, Muñoz AJ, Calles A. Aparicio I, et al. Among authors: camps c. Thromb Res. 2023 Dec;232:133-137. doi: 10.1016/j.thromres.2023.11.007. Epub 2023 Nov 12. Thromb Res. 2023. PMID: 37976733
Difficulties on the access to innovative targeted therapies for lung cancer in Spain.
Calvo V, Camps C, Carcereny E, Cobo M, Dómine M, García Campelo MR, González Larriba JL, Guirado M, Hernando-Trancho F, Massutí B, Nadal E, Rodríguez-Abreu D, Sánchez A, Sullivan IG, Provencio M; Spanish Lung Cancer Group (SLCG/GECP). Calvo V, et al. Among authors: camps c. Clin Transl Oncol. 2024 Mar;26(3):597-612. doi: 10.1007/s12094-023-03303-5. Epub 2023 Aug 31. Clin Transl Oncol. 2024. PMID: 37651020 Free PMC article. Review.
Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma.
Torres-Martínez S, Calabuig-Fariñas S, Moreno-Manuel A, Bertolini G, Herreros-Pomares A, Escorihuela E, Duréndez-Saéz E, Guijarro R, Blasco A, Roz L, Camps C, Jantus-Lewintre E. Torres-Martínez S, et al. Among authors: camps c. Mol Oncol. 2024 Jan;18(1):190-215. doi: 10.1002/1878-0261.13505. Epub 2023 Nov 1. Mol Oncol. 2024. PMID: 37567864 Free PMC article.
135 results